BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) ☒ September 30, 2017

[FORM 10-Q (Mark One) ☒ September 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Nu]

By | 2017-11-21T03:49:02+00:00 November 20th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] NT 10-Q: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: September 30, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained h]

By | 2017-11-16T03:05:27+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] NT 10-Q: FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER:

[FORM 12b-25 NOTIFICATION OF LATE FILING CUSIP NUMBER: 090678 301 o o o (Check One): x o o For Period Ended: September 30, 2017 o o o o o For the Transition Period Ended: ____________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained h]

By | 2017-11-16T03:05:30+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]

By | 2017-11-16T03:06:21+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) ☒ June 30, 2017

[FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number)]

By | 2017-11-16T03:06:24+00:00 November 15th, 2017|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel BEIJING, November 8, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Company submitted a request for a hear]

By | 2017-11-09T04:17:16+00:00 November 8th, 2017|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Request Hearing before Nasdaq Hearings

[Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel BEIJING, November 8, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Company submitted a request for a hear]

By | 2017-11-09T04:17:20+00:00 November 8th, 2017|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar